TASE Site - Profile

Hebrew

English

Advanced Search

Homepage

My TASE

Market Data

Products

Trading & Clearing

Listings

News & Events

Statistics

Publications

Rules & Regulations

About TASE

PROTALIX BIOTHERAPEUTICS INC

Summary

Profile

Charts

Historical Prices

Turnover Statistics

Company Disclosures

www.protalix.com

Issuer No.

Corporate No.

Market Cap (19/06/2013)

1554

1,688,976 NIS thousands

Market Sector

Market Subsector

Indices

BIOMED

BIOTECHNOLOGY

TA75 Index, TA100 Index, TA-Biomed Index, TA BlueTech-50 Index, TA Composite Index, Additional Indices


Contact Details :
Phone : 04-9889488
Fax : 04-9889489
YOSSIM@PROTALIX.COM


Interested Parties:

List of Interested Parties

Name	Balance Date	Symbol	Balance	% Capital	% Voting	Market Cap (NIS millions)
ביוסל	31/08/2010	PLX	14,466,319	15.93	15.93	264.20
פדרטד אינווסט(ז	31/12/2012	PLX	10,665,296	11.75	11.75	194.80
Al-rov (Israel) LTD	11/03/2013	PLX	5,027,713	5.54	5.54	91.80
שאלתיאל יוסף	02/05/2012	PLX	463,754	0.51	0.51	8.40
שאלתיאל יוסף	15/09/2011	*	580,890	-	-	-
אביעזר דוד	02/05/2012	*	1,803,564	-	-	-
מימון יוסף	06/05/2012	*	305,000	-	-	-
אלמון עינת	06/05/2012	*	441,272	-	-	-
פלש צבי	29/08/2010	*	160,000	-	-	-
קורנברג רוג'ר(ז)	15/09/2010	*	50,000	-	-	-
לאוטרבאך סנדרה(ז)	15/09/2010	*	160,000	-	-	-

Open in a Separate Window

* Non Tradable

List of Securities

Name	Symbol	ISIN	Issued and Paid-Up Share Capital	Capital Listed for Trading	Market Cap (NIS millions)	% Capital	% Voting
PROTALIX	PLX	US74365A1016	90,805,157	90,805,157	1,659	100	100
*		IL0011206179	6,747,856	-	-	-	-
*		IL0011206252	631,866	-	-	-	-

Open in a Separate Window

* Non Tradable

The Company is a foreign corporation and owes reporting duties in accordance with Chapter 5C of the Securities Law ('a dual listed company'). The capital data of the Company in the Stock Exchange records are updated in accordance with the information given to the Stock Exchange by the Company when it applies to the Stock Exchange for approval to list for trading on the Stock Exchange new securities that are issued by it and offered to the public or through a private placement, and also information given to the Stock Exchange by the Company concerning the exercise of its convertible securities. It should be noted that there might be differences between the capital data published by the Stock Exchange and the capital data published by the Company. The differences inter alia derive from the data being updated at different frequency.

Indices

As of 20/06/2013

Name	Symbol	ISIN	Index	Weight (%)	Weight Factor *
PROTALIX	PLX	US74365A1016	General Shares and Convertibles	0.27
PROTALIX	PLX	US74365A1016	Shares	0.27
PROTALIX	PLX	US74365A1016	TA-100	0.56	1
PROTALIX	PLX	US74365A1016	TA-75	2.29	1
PROTALIX	PLX	US74365A1016	TA BlueTech-50	4.15	1
PROTALIX	PLX	US74365A1016	TA-Biomed	9.68	0.68951
PROTALIX	PLX	US74365A1016	TA Composite	0.52	1

Export Table Data

Open in a Separate Window

* Weight factor is calculated for universe indices only

Index Adjusted Data for Company Securities

As of 20/06/2013

Name	Symbol	ISIN	Index Adjusted No. of Shares (IANS) *	Index Adjusted Free Float Class **	Index Adjusted Free Float Rate **	Last IANS Update	Index Adjusted Free Float Market Cap. (NIS millions) **
PROTALIX	PLX	US74365A1016	90,805,157	F	80%	15/03/2012	1,351

Export Table Data

Open in a Separate Window

* IANS - Index Adjusted Number of Shares – listed capital for calculation a security's weight in the index.
For more details, press here.
** Index Adjusted Float Data for calculation of a share's weight in the index, for universe indices.
Free float class is published since 1/7/2010.For more details, press here.

Financial Statements – Key Data (NIS thousands) **

	March 2013 IFRS	March 2012 IFRS	Yearly 2012 IFRS
Balance Sheet
Total Assets	255,148	254,344	293,888
Current Assets	192,957	185,144	228,348
Non Current Assets	62,191	69,199	65,540
Shareholders Equity	-22,920	-23,988	-12,532
Of which Minority Interest	0	0	0
Current Liabilities	89,040	65,845	96,143
Long-Term Liabilities	189,028	212,487	210,276
Profit & Loss Statement
Revenues	14,475	13,850	41,974
Gross Profit	10,933	8,946	25,612
Operating Income	-16,157	-22,531	-111,863
Income Before Tax	-15,763	-21,933	-108,250
Net Income	-15,763	-21,933	-108,250
Income Attributable to Shareholders	-15,763	-21,933	-108,250
Earnings per Share	0.18	0.26	-1.34
Additional Data
Dividends	0	0	0
Net cash flow generated by operating activities	-34,970	-23,334	-143,586
Financial Ratios
Market to book value	---	---	---
Price-Earning Ratio	Loss	---	Loss
Equity-Assets Ratio	---	---	---
Return on Equity	Loss	Loss	Loss

Export Table Data

Note: The financial statements data have been obtained from A-Online and they were compiled and processed by it. The data have not been examined or audited by the Stock Exchange and they are presented as given to the Stock Exchange by A-Online.
The binding data are those appearing in the financial statements published by the Company. Without derogating from the provisions of the use agreement , the Stock Exchange is not liable for any fault, error, mistake or inaccuracy in the data presented. Financial statements published in foreign currency are translated to NIS according to the exchange rate at the date of the financial statements.
Financial Ratios: Market Capitalization – as of previous end-of-trading day ; Net income – Attributable to Shareholders (annualized); Shareholders' Equity- excluding Minority Interest.